These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 30775943)

  • 1. Health state utilities associated with treatment options for acute myeloid leukemia (AML).
    Matza LS; Deger KA; Howell TA; Koetter K; Yeager AM; Hogge D; Fisher V; Louie AC; Chung KC
    J Med Econ; 2019 Jun; 22(6):567-576. PubMed ID: 30775943
    [No Abstract]   [Full Text] [Related]  

  • 2. Dosing of 7 + 3 induction chemotherapy in a patient with acute myeloid leukemia (AML) and morbid obesity.
    Franco S; Khan T; Dinner S; Karmali R; Melody M
    J Oncol Pharm Pract; 2024 Jul; 30(5):945-949. PubMed ID: 38509800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase 1/2 study of NS-87/CPX-351 (cytarabine and daunorubicin liposome) in Japanese patients with high-risk acute myeloid leukemia.
    Usuki K; Miyamoto T; Yamauchi T; Ando K; Ogawa Y; Onozawa M; Yamauchi T; Kiyoi H; Yokota A; Ikezoe T; Katsuoka Y; Takada S; Aotsuka N; Morita Y; Ishikawa T; Asada N; Ota S; Dohi A; Morimoto K; Imai S; Kishimoto U; Akashi K; Miyazaki Y;
    Int J Hematol; 2024 Jun; 119(6):647-659. PubMed ID: 38532078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic burden of acute myeloid leukemia: a literature review.
    Redaelli A; Botteman MF; Stephens JM; Brandt S; Pashos CL
    Cancer Treat Rev; 2004 May; 30(3):237-47. PubMed ID: 15059647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health state utilities associated with attributes of migraine preventive treatments based on patient and general population preferences.
    Matza LS; Deger KA; Vo P; Maniyar F; Goadsby PJ
    Qual Life Res; 2019 Sep; 28(9):2359-2372. PubMed ID: 30924071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incorporation of Novel therapies for the treatment of acute myeloid leukemia: a perspective.
    Waksal JA; Tallman MS
    Leuk Lymphoma; 2021 Apr; 62(4):779-790. PubMed ID: 33541192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilities associated with subcutaneous injections and intravenous infusions for treatment of patients with bone metastases.
    Matza LS; Cong Z; Chung K; Stopeck A; Tonkin K; Brown J; Braun A; Van Brunt K; McDaniel K
    Patient Prefer Adherence; 2013; 7():855-65. PubMed ID: 24039408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CPX-351 exploits the gut microbiota to promote mucosal barrier function, colonization resistance, and immune homeostasis.
    Renga G; Nunzi E; Stincardini C; Pariano M; Puccetti M; Pieraccini G; Di Serio C; Fraziano M; Poerio N; Oikonomou V; Mosci P; Garaci E; Fianchi L; Pagano L; Romani L
    Blood; 2024 Apr; 143(16):1628-1645. PubMed ID: 38227935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health state utilities for non small cell lung cancer.
    Nafees B; Stafford M; Gavriel S; Bhalla S; Watkins J
    Health Qual Life Outcomes; 2008 Oct; 6():84. PubMed ID: 18939982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Treatment Advances and the Role of Nanotechnology, Combination Products, and Immunotherapy in Changing the Therapeutic Landscape of Acute Myeloid Leukemia.
    Chen KTJ; Gilabert-Oriol R; Bally MB; Leung AWY
    Pharm Res; 2019 Jun; 36(9):125. PubMed ID: 31236772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of an embedded primary care-derived electronic health record (EHR) frailty index (eFI) in older adults with acute myeloid leukemia.
    Cheng JJ; Tooze JA; Callahan KE; Pajewski NM; Pardee TS; Reed DR; Klepin HD
    J Geriatr Oncol; 2023 Sep; 14(7):101509. PubMed ID: 37454532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivering HDAC over 3 or 5 days as consolidation in AML impacts health care resource consumption but not outcome.
    Dumas PY; Bertoli S; Bérard E; Leguay T; Tavitian S; Galtier J; Alric C; Bidet A; Delabesse E; Rieu JB; Vial JP; Vergez F; Lechevalier N; Luquet I; Klein E; Sarry A; Rey H; de Grande AC; Despas F; Pigneux A; Récher C
    Blood Adv; 2020 Aug; 4(16):3840-3849. PubMed ID: 32790847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose azacitidine, pioglitazone and all-
    Heudobler D; Luke F; Hahn J; Grube M; Schlosser P; Kremers S; Sudhoff T; Westermann J; Hutter-Kronke ML; Schlenk RF; Weber D; Paschka P; Zeman F; Dohner H; Herr W; Reichle A; Thomas S
    Haematologica; 2024 Apr; 109(4):1274-1278. PubMed ID: 37881883
    [No Abstract]   [Full Text] [Related]  

  • 14. Uptake of novel therapies into first-line treatment for acute myeloid leukemia patients: EU4 + UK perspective.
    Ruiz M; Jindal K; Casey V; Soares LM; Manuguid F; Moehler T
    Future Oncol; 2024 Mar; 20(9):533-546. PubMed ID: 37975244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SOHO State of the Art Updates and Next Questions: Oral Therapy in Acute Myeloid Leukemia.
    Nasnas P; Ravandi F
    Clin Lymphoma Myeloma Leuk; 2024 Apr; 24(4):205-213. PubMed ID: 38114391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CREST-UK: Real-world effectiveness, safety and outpatient delivery of CPX-351 for first-line treatment of newly diagnosed therapy-related AML and AML with myelodysplasia-related changes in the UK.
    Mehta P; Campbell V; Maddox J; Floisand Y; Kalakonda AJM; O'Nions J; Coats T; Nagumantry S; Hodgson K; Whitmill R; Amott I; Flynn G; Taussig D; Zhao R; Cunningham N; Roset M; Cuadras D; Medalla G; Kuter H; Park S; Legg A; Khan AB
    Br J Haematol; 2024 Jul; ():. PubMed ID: 38977430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outpatient care of patients with acute myeloid leukemia: Benefits, barriers, and future considerations.
    Vaughn JE; Buckley SA; Walter RB
    Leuk Res; 2016 Jun; 45():53-8. PubMed ID: 27101148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leveraging machine learning to identify acute myeloid leukemia patients and their chemotherapy regimens in an administrative database.
    Cao L; Huang YS; Wu C; Getz K; Miller TP; Ruiz J; Fisher BT; Seif AE; Aplenc R; Li Y
    Pediatr Blood Cancer; 2023 May; 70(5):e30260. PubMed ID: 36815580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Care Patterns and Barriers to Outpatient Care for Adults With AML Following Intensive Chemotherapy at NCCN Member Institutions.
    Halpern AB; Sugalski JM; Bandini L; Othus M; Stewart FM; Walter RB
    J Natl Compr Canc Netw; 2024 Jul; 22(7):469-474. PubMed ID: 39079559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Chemotherapy Educational Videos for Patients with Acute Myeloid Leukemia.
    Gabbard T; Perissinotti AJ; Benitez LL; Fraga M; Pettit KM; Bixby DL; Burke PW; Marini BL
    J Cancer Educ; 2024 Jul; ():. PubMed ID: 38955941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.